Results 31 to 40 of about 257,222 (353)

Middle bile duct cancer with portal vein tumor thrombus

open access: yesWorld Journal of Surgical Oncology, 2008
Background Tumor thrombus in the portal vein is a common complication of hepatocellular carcinoma, but an extremely rare complication of common bile duct cancer.
Murakami Koji   +6 more
doaj   +1 more source

Extensively Invasive Gallbladder Cancer from Intracholecystic Papillary Neoplasm Treated with Pylorus-Preserving Pancreaticoduodenectomy and Extended Cholecystectomy: A Case Report and Literature Review

open access: yesCase Reports in Surgery, 2023
Background. Intracholecystic papillary neoplasm (ICPN) is a rare tumor first classified by the World Health Organization in 2010. ICPN is a counterpart of the intraductal papillary mucinous neoplasm of the pancreas and intraductal papillary neoplasm of ...
Hideki Kumagai   +7 more
doaj   +1 more source

Pattern of distant metastases in primary extrahepatic bile‐duct cancer: A SEER‐based study

open access: yesCancer Medicine, 2018
Extrahepatic bile duct cancer (EBDC) is a combined type of malignancy mainly consisting of extrahepatic cholangiocarcinoma and gallbladder cancer.
Xuan Wang   +5 more
semanticscholar   +1 more source

Results of Radical Surgical Treatment of Cholangiocarcinoma [PDF]

open access: yes, 2017
Radical operations of cholangiocarcinomas are connected with the great number of post-operative complications, and lethality reaches 15-30 %. The most debatable questions remain the choice of the operation type depending on localization and spreading of ...
Avdosyev, Y. (Yuriy)   +2 more
core   +2 more sources

Unclassified autoimmune pancreatitis mimicking pancreatic cancer [PDF]

open access: yes, 2019
A 24-year-old black male presented with a 1-week obstructive jaundice and intermittent abdominal pain, with no significant weight loss and an unsuspicious abdominal exam.
Alves, A   +3 more
core   +1 more source

miR-122-5p Inhibits the Proliferation, Invasion and Growth of Bile Duct Carcinoma Cells by Targeting ALDOA

open access: yesCellular Physiology and Biochemistry, 2018
Background/Aims: Bile duct cancer, although not among the most common tumors, still accounts for more and more worldwide deaths each year. By attempting to verify an overexpression of ALDOA in cholangiocarcinoma tissues and cells and explore the ...
Zhuo Xu   +9 more
doaj   +1 more source

Liver: Intrahepatic cholangiocarcinoma [PDF]

open access: yes, 2009
Review on Liver: Intrahepatic cholangiocarcinoma, with data on clinics, and the genes ...
Aishima, S, Enjoji, M
core   +1 more source

Ceruloplasmin as a prognostic marker in patients with bile duct cancer

open access: yesOncoTarget, 2017
Background and Aims Bile duct cancer is one of the lethal cancers, presenting difficulties in early diagnosis and limited treatment modalities. Despite current advances in biomarker research, most studies have been performed in Western populations ...
I. Han   +6 more
semanticscholar   +1 more source

Bile duct segmental resection versus pancreatoduodenectomy for middle and distal common bile duct cancer

open access: yesAnnals of Surgical Treatment and Research, 2018
Purpose To compare survival outcomes between bile duct segmental resection (BDR) and pancreatoduodenectomy (PD) for the treatment of middle and distal bile duct cancer.
Naru Kim   +3 more
semanticscholar   +1 more source

Histamine stimulates the proliferation of small and large cholangiocytes by activation of both IP3/Ca2+ and cAMP-dependent signaling mechanisms [PDF]

open access: yes, 2012
Although large cholangiocytes exert their functions by activation of cyclic adenosine 3',5'-monophosphate (cAMP), Ca(2+)-dependent signaling regulates the function of small cholangiocytes. Histamine interacts with four receptors, H1-H4HRs.
Fanyin Meng   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy